235 related articles for article (PubMed ID: 34156100)
1. A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.
Kozlyuk N; Gilston BA; Salay LE; Gogliotti RD; Christov PP; Kim K; Ovee M; Waterson AG; Chazin WJ
Proteins; 2021 Nov; 89(11):1399-1412. PubMed ID: 34156100
[TBL] [Abstract][Full Text] [Related]
2. Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast.
Chiou JW; Fu B; Chou RH; Yu C
PLoS One; 2016; 11(9):e0162000. PubMed ID: 27598566
[TBL] [Abstract][Full Text] [Related]
3. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
4. A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE).
Degani G; Altomare AA; Colzani M; Martino C; Mazzolari A; Fritz G; Vistoli G; Popolo L; Aldini G
Redox Biol; 2017 Apr; 11():275-285. PubMed ID: 28013188
[TBL] [Abstract][Full Text] [Related]
5. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
[TBL] [Abstract][Full Text] [Related]
6. Generation, biochemical characterizations and validation of potent nanobodies derived from alpaca specific for human receptor of advanced glycation end product.
Mohammed A; Zeng W; Mengist HM; Kombe Kombe AJ; Ou H; Yang Y; Dan Z; Xu Z; Ma H; Jin T
Biochem Biophys Res Commun; 2021 Dec; 581():38-45. PubMed ID: 34653677
[TBL] [Abstract][Full Text] [Related]
7. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products.
Yatime L; Andersen GR
FEBS J; 2013 Dec; 280(24):6556-68. PubMed ID: 24119142
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
Bongarzone S; Savickas V; Luzi F; Gee AD
J Med Chem; 2017 Sep; 60(17):7213-7232. PubMed ID: 28482155
[TBL] [Abstract][Full Text] [Related]
10. The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding.
Park H; Adsit FG; Boyington JC
J Biol Chem; 2010 Dec; 285(52):40762-70. PubMed ID: 20943659
[TBL] [Abstract][Full Text] [Related]
11. Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.
Kim HJ; Jeong MS; Jang SB
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199060
[TBL] [Abstract][Full Text] [Related]
12. Biophysical characterization of the ETV6 PNT domain polymerization interfaces.
Gerak CAN; Cho SY; Kolesnikov M; Okon M; Murphy MEP; Sessions RB; Roberge M; McIntosh LP
J Biol Chem; 2021; 296():100284. PubMed ID: 33450226
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).
Xie J; Reverdatto S; Frolov A; Hoffmann R; Burz DS; Shekhtman A
J Biol Chem; 2008 Oct; 283(40):27255-69. PubMed ID: 18667420
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RAGE Axis Signaling: A Pharmacological Challenge.
Rojas A; Morales M; Gonzalez I; Araya P
Curr Drug Targets; 2019; 20(3):340-346. PubMed ID: 30124149
[TBL] [Abstract][Full Text] [Related]
15. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.
Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of carboxypeptidase T complexes with transition-state analogs.
Akparov VK; Timofeev VI; Khaliullin IG; Švedas V; Kuranova IP; Rakitina TV
J Biomol Struct Dyn; 2018 Nov; 36(15):3958-3966. PubMed ID: 29129130
[No Abstract] [Full Text] [Related]
17. The interplay of protein-ligand and water-mediated interactions shape affinity and selectivity in the LAO binding protein.
Vergara R; Romero-Romero S; Velázquez-López I; Espinoza-Pérez G; Rodríguez-Hernández A; Pulido NO; Sosa-Peinado A; Rodríguez-Romero A; Fernández-Velasco DA
FEBS J; 2020 Feb; 287(4):763-782. PubMed ID: 31348608
[TBL] [Abstract][Full Text] [Related]
18. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
Huang YK; Chou RH; Yu C
J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
[TBL] [Abstract][Full Text] [Related]
19. Structure and Analysis of R1 and R2 Pyocin Receptor-Binding Fibers.
Buth SA; Shneider MM; Scholl D; Leiman PG
Viruses; 2018 Aug; 10(8):. PubMed ID: 30110933
[TBL] [Abstract][Full Text] [Related]
20. Differential gene expression analysis of RAGE-S100A6 complex for target selection and the design of novel inhibitors for anticancer drug discovery.
Faruqui T; Singh G; Khan S; Khan MS; Akhter Y
J Cell Biochem; 2023 Feb; 124(2):205-220. PubMed ID: 36502516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
